Ignite Creation Date:
2025-12-24 @ 2:55 PM
Ignite Modification Date:
2026-03-03 @ 1:11 AM
Study NCT ID:
NCT05824559
Status:
TERMINATED
Last Update Posted:
2024-11-21
First Post:
2023-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
ME-344 and Bevacizumab in Previously Treated Metastatic Colorectal Cancer
Sponsor:
MEI Pharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ME-344-003
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None